Sawtooth Asset Management »

Theravance Biopharma shares owned by Sawtooth Asset Management

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by Sawtooth Asset Management from 13F filings

Historical chart of Sawtooth Asset Management investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by Sawtooth Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by Sawtooth Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $141k 13k 11.24
2023-06-30 $245k 24k 10.35

More positions owned by Sawtooth Asset Management

Mirati Therapeutics
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
Sprott Physical Gold & Silve Tr Unit (CEF)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Sprott Physical Gold Tr Unit (PHYS)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Amazon (AMZN)

View all positions for Sawtooth Asset Management

Top funds holding Theravance Biopharma

Weiss Asset Management LP[1
Madison Avenue Partners
Baupost Group
BlackRock
Irenic Capital Management
Newtyn Management
Pictet Asset Management Holding SA
Vanguard Group
Park West Asset Management
State Street Corporation
Oasis Management
Camber Capital Management
Geode Capital Management
D. E. Shaw & Co
Jacobs Levy Equity Management

View all funds holding Theravance Biopharma